The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Hantz Financial Services Inc.

Hantz Financial Services Inc. cut its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1.8% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 101,444 shares of the medical device company’s stock after selling 1,847 shares during the quarter. Hantz Financial Services Inc. owned 0.05% of Cooper Companies worth $9,326,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Ashton Thomas Securities LLC acquired a new position in shares of Cooper Companies in the third quarter worth $25,000. Covestor Ltd raised its holdings in shares of Cooper Companies by 144.9% in the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after acquiring an additional 200 shares during the last quarter. Brown Brothers Harriman & Co. raised its holdings in shares of Cooper Companies by 191.0% in the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock worth $46,000 after acquiring an additional 275 shares during the last quarter. West Financial Advisors LLC acquired a new position in shares of Cooper Companies in the fourth quarter worth $49,000. Finally, Friedenthal Financial acquired a new position in shares of Cooper Companies in the third quarter worth $50,000. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Trading Down 0.5 %

Shares of COO opened at $98.00 on Thursday. The stock’s 50-day moving average is $95.91 and its two-hundred day moving average is $99.54. The stock has a market cap of $19.56 billion, a PE ratio of 50.26, a P/E/G ratio of 2.41 and a beta of 0.99. The Cooper Companies, Inc. has a 12 month low of $84.76 and a 12 month high of $112.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, topping the consensus estimate of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.03 billion. During the same quarter in the previous year, the firm posted $0.87 earnings per share. The company’s revenue was up 9.8% compared to the same quarter last year. Equities analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

COO has been the subject of a number of analyst reports. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. Citigroup lowered their price objective on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research report on Friday, December 6th. Morgan Stanley lowered their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Friday, December 6th. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Finally, Wells Fargo & Company lifted their price objective on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, December 6th. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Cooper Companies presently has a consensus rating of “Moderate Buy” and an average target price of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.